Gujarat Kidney & Super Speciality IPO Review

Gujarat Kidney & Super Speciality IPO has been reviewed by 10 analysts, and the overall consensus is Apply — carrying a score of 72. Out of the 10 analysts who have covered this IPO, 6 recommend subscribing while 4 advise caution or avoidance — reflecting a broadly positive view from the analyst community.

The issue is priced in the band of ₹108 to 114 per share , with a minimum application size of 128 shares (minimum investment of approximately ₹13,824 at the upper band) . Subscription ran from 22 Dec 2025 to 24 Dec 2025. As of now, the grey market premium (GMP) for Gujarat Kidney & Super Speciality IPO is quoting at ₹55 (10%%), which gives a preliminary sense of how the street is pricing the listing — though GMP is unofficial and can swing sharply before the listing date. Scroll down for the full analyst breakdown and analyst-wise verdicts.